We are live on ! Find out more
AF

Avanza Fonder Portfolio holdings

AUM $4.59B
1-Year Est. Return 41.03%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+41.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.86B
AUM Growth
+$480M
Cap. Flow
+$182M
Cap. Flow %
4.72%
Top 10 Hldgs %
47.14%
Holding
436
New
3
Increased
192
Reduced
24
Closed
8

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$33.1M
2
MSFT icon
Microsoft
MSFT
+$18.8M
3
AAPL icon
Apple
AAPL
+$8.59M
4
AMZN icon
Amazon
AMZN
+$6.28M
5
META icon
Meta Platforms (Facebook)
META
+$4.57M

Sector Composition

Rank Sector Weight
1 Technology 39.49%
2 Consumer Discretionary 14.58%
3 Financials 11.61%
4 Communication Services 10.72%
5 Healthcare 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RY icon
26
Royal Bank of Canada
RY
$287B
$19M 0.49%
92,872
+2,921
+3% +$403K
ISRG icon
27
Intuitive Surgical
ISRG
$127B
$18.4M 0.48%
41,050
+3,031
+8% +$1.45M
GS icon
28
Goldman Sachs
GS
$289B
$18.1M 0.47%
22,695
+1,950
+9% +$1.44M
QCOM icon
29
Qualcomm
QCOM
$164B
$17.8M 0.46%
106,834
+4,902
+5% +$778K
IBM icon
30
IBM
IBM
$213B
$17.2M 0.45%
61,032
+75
+0.1% +$19.6K
GEV icon
31
GE Vernova
GEV
$240B
$17.1M 0.44%
27,791
+1,834
+7% +$1.11M
TJX icon
32
TJX Companies
TJX
$179B
$16.5M 0.43%
114,211
+3,885
+4% +$516K
AMGN icon
33
Amgen
AMGN
$209B
$16.1M 0.42%
57,207
+4,546
+9% +$1.32M
AMAT icon
34
Applied Materials
AMAT
$347B
$16M 0.41%
78,057
+6,060
+8% +$1.1M
LRCX icon
35
Lam Research
LRCX
$316B
$15.9M 0.41%
118,465
+4,246
+4% +$450K
BSX icon
36
Boston Scientific
BSX
$68.4B
$15.8M 0.41%
161,769
+3,676
+2% +$381K
CRM icon
37
Salesforce
CRM
$154B
$15.7M 0.41%
66,038
+3,059
+5% +$772K
T icon
38
AT&T
T
$164B
$14.9M 0.39%
528,088
+37,218
+8% +$1.06M
DIS icon
39
Walt Disney
DIS
$171B
$14.8M 0.38%
129,419
+8,720
+7% +$1.03M
MU icon
40
Micron Technology
MU
$835B
$14.8M 0.38%
88,234
-853
-1% -$109K
PFE icon
41
Pfizer
PFE
$143B
$14.7M 0.38%
578,638
+39,568
+7% +$977K
SYK icon
42
Stryker
SYK
$135B
$14.5M 0.38%
39,202
+1,485
+4% +$574K
MS icon
43
Morgan Stanley
MS
$319B
$14.2M 0.37%
89,030
+6,536
+8% +$965K
GILD icon
44
Gilead Sciences
GILD
$165B
$14.1M 0.37%
127,039
+574
+0.5% +$65.2K
TMO icon
45
Thermo Fisher Scientific
TMO
$214B
$14M 0.36%
28,804
+1,278
+5% +$595K
C icon
46
Citigroup
C
$213B
$13.9M 0.36%
136,772
+12,832
+10% +$1.22M
VZ icon
47
Verizon
VZ
$197B
$13.8M 0.36%
314,467
+21,672
+7% +$938K
INTU icon
48
Intuit
INTU
$91.1B
$13.8M 0.36%
20,234
+968
+5% +$698K
ANET icon
49
Arista Networks
ANET
$199B
$13.6M 0.35%
93,116
+3,751
+4% +$483K
LOW icon
50
Lowe's Companies
LOW
$121B
$13.3M 0.34%
52,909
+248
+0.5% +$60.9K

Similar funds

Avanza Fonder's Q3 2025 Portfolio in Review

As of Q3 2025, Avanza Fonder held 436 positions worth $3.86B, up 14% from $3.38B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Avanza Fonder deployed $182M of net new capital in Q3 2025, opening 3 new positions and adding to 192 existing holdings. Its largest new stake was Avidity Biosciences: 2,153 shares worth $93.8K.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $2.48M trimmed.

  • Avanza Fonder's largest Q3 2025 buy was Avidity Biosciences: 2,153 shares worth $93.8K.
  • Avanza Fonder added most to NVIDIA in Q3 2025, an estimated $33.1M increase.
  • Avanza Fonder's biggest Q3 2025 reduction was Alphabet (Google) Class A, cutting an estimated $2.48M.
  • Avanza Fonder fully exited Ansys in Q3 2025, selling an estimated $2.38M.
  • Avanza Fonder's ten largest holdings make up 47% of its $3.86B portfolio in Q3 2025.
  • Avanza Fonder opened 3 new positions and closed 8 in Q3 2025.
  • Avanza Fonder's portfolio value rose 14% quarter-over-quarter to $3.86B.

Based on Avanza Fonder's 13F filing for Q3 2025, filed 16 Oct 2025.